Mice Model Market

Charles River Laboratories (US), THE JACKSON LABORATORY (US) are Leading players in the Mice Model Market

The mice model market is projected to reach USD 2.2 billion by 2029 from an estimated USD 1.5 billion in 2024, at a CAGR of 8.1% during the forecast period. The major factors driving the growth of this mice model market include rising demand for personalized medicines for oncology, growing prevalence of chronic and genetic diseases, and rising demand for disease specific mice models.

The global mice model market is consolidated with top players such as Charles River Laboratories (US), THE JACKSON LABORATORY (US), and Inotiv (US). The market players have adopted various strategies such as new product launches, acquisitions, agreements, collaborations, partnership, and geographical expansions to strengthen their position in the global mice model market.

To know about the assumptions considered for the study download the pdf brochure

Charles River Laboratories (US)

Charles River Laboratories is a leading player in the global mice model market due to its broad portfolio of mice models and services. Drawing on over 70 years of expertise, the company has expanded its foundational strength in in vivo biology across a broad spectrum of offerings. Its comprehensive portfolio encompasses products, services, and solutions tailored to early-stage drug discovery and preclinical development. Additionally, Charles River offers an array of supportive services aimed at assisting clients in leveraging research models for drug discovery and development. Boasting a selection of more than 150 distinct stocks and strains, the company is actively involved in manufacturing and distributing the most commonly utilized rodent research model strains, as well as purpose-bred rats and mice. The company is expanding its business through inorganic growth strategies. For instance, In July 2022, Charles River Laboratories entered into a license agreement with GemPharmaTech (US) to exclusively distribute its next-generation NOD CRISPR Prkdc Il2r gamma (NCG) mouse lines in North America.


The Jackson Laboratory has a portfolio of over 11,000 mice strains. The company specializes in the development and distribution of proprietary mice models created in-house. Its mice model business has been bolstered by numerous grants aimed at advancing its development efforts. In recent years, the company has secured funding from prominent health organizations and academic institutions, including the National Cancer Institute (NCI), the National Institutes of Health (NIH), The Mark Foundation for Cancer Research, the National Institute on Deafness and Other Communication Disorders, the National Institute of Neurological Disorders and Stroke, and the Howard Hughes Medical Institute (HHMI), among various others. For instance, in 2022, JAX secured more than USD 130 million in fresh federal, peer-reviewed foundation, and external funding, showcasing an outstanding success rate exceeding 36% during the third quarter of the year. This financial support has been instrumental in the company's efforts to advance the development of novel models, undertake targeted studies utilizing these models, generate comprehensive genome-scale datasets for both mice and humans and analyze diverse patterns of gene expression in mice. These initiatives aim to deepen our comprehension of the genetic mechanisms underlying both normal development and disease.

Inotiv (US)

Leveraging its fundamental expertise in preclinical and non-clinical contract research, as well as research models and services, the company has expanded its offerings. Its diverse portfolio includes an extensive array of mice models and services. The company operates in the mice model market through its subsidiary Envigo. The company offers research & discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, and surgical models & medical devices. The company’s services for non-clinical safety assessment include general & genetic toxicology, regulated bioanalysis, biotherapeutics, and development & reproductive toxicology. It also provides pathology & consulting services. The company operates in North America, South America, Europe, and other international markets

Related Reports:

Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Mice Model Market Size,  Share & Growth Report
Report Code
BT 2192
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status